Delivery Order SPE2DB20D3111-SPE2DB25FA8XP
- Not listed
- The Defense Logistics Agency awarded a $1,069.96 delivery order to AmerisourceBergen Drug Corp for Humalog 100 Unit/ML KwikPen 3ML insulin pens, with an ultimate completion date of July 22, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Humalog 100 Unit/mL KwikPen 3mL insulin pens at a firm fixed price of $2,082.52, with an ultimate completion date of July 21, 2025. This is a non-set-aside, competitively awarded contract performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Humalog 100 Unit/mL KwikPen 3mL insulin pens, with a ceiling value of $1,048.07. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,815.02 to supply Humalog 100 Unit/mL KwikPen 3 mL insulin pens. This is a firm fixed-price delivery order with no set-aside designation, completed on August 1, 2025, and fulfills pharmaceutical supply requirements for federal medical procurement. The award leverages AmerisourceBergen's established capacity as a critical pharmaceutical distributor within the federal supply chain, particularly for...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract (SPE2DB24FTGQ9) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply Humalog 100 unit/mL KwikPen 3mL insulin pens. The delivery order is valued at $1,024.32 and has a performance period through March 18, 2024. This delivery order is placed under a larger indefinite delivery contract (SPE2DB22D1103) awarded solely to AmerisourceBergen Drug Corp, with a potential value...
- The Defense Logistics Agency awarded a $1,270.98 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562126604 Humalog 100 unit/ml KwikPen 3ml insulin delivery devices. The order was placed under an existing prime vendor contract vehicle to support the Department of Defense's medical supply needs. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania by September 12, 2023. No subcontractors or set aside...
- This is a $7,069.86 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a prescription insulin medication. The order has an ultimate completion date of August 21, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the United States, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens, valued at $6,578.04. This competitively awarded, firm fixed-price delivery order is set to be completed by August 14, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a discrete pharmaceutical procurement under AmerisourceBergen's broader federal...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,589.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Humalog 100 unit/mL Kwikpen 3mL, a diabetes medication. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a global pharmaceutical support vehicle through...
- The Defense Logistics Agency awarded a $145,850 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 unit/ml Humalog KwikPens. The order is for 3 ml of the insulin product and will be delivered to a location in Conshohocken, Pennsylvania by August 31, 2023. Amerisourcebergen will serve as the prime contractor to fulfill this requirement for injectable diabetes medication in support of Department of Defense health programs. No major subcontractors or set aside...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB25FA8XPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,227.19 to supply Humalog 100 Unit/mL KwikPen 3mL insulin pens. This contract, which was not set-aside for small business, was executed on August 14, 2025, with an ultimate completion date of August 15, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. The delivery order operates under a firm fixed price structure, typical for pharmaceutical procurement through federal medical supply channels. This delivery order is a child contract executed under AmerisourceBergen Drug Corp's substantially larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. This comprehensive pharmaceutical support vehicle enables AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through competitively awarded contracts that consistently demonstrate the company's capability to fulfill diverse medical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/14/25 |